Statistics
Publications
10
Citations
2K
H-Index
10
Active since
2016
Eliza Yankova is an author at University of Cambridge specializing in pharmacology, medicine, and molecular oncology.
Publications per year
2016–2025
10
10
Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia
Eliza Yankova, Wesley Blackaby, Mark R. Albertella et al. · Nature · 2021 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +13
METTL1-mediated m7G modification of Arg-TCT tRNA drives oncogenic transformation
Esteban A. Orellana, Qi Liu, Eliza Yankova et al. · Molecular Cell · 2021 · 362 citations · Full text
Identification of SARS-CoV-2–induced pathways reveals drug repurposing strategies
Namshik Han, Woochang Hwang, Konstantinos Tzelepis et al. · Science Advances · 2021 · 61 citations · Full text
1–5 of 10